Gravar-mail: ANGI-09 COMPARISON OF PROGRESSION PATTERN (PP) AND ADVERSE EVENTS (AES) WITH USE OF BEVACIZUMAB (BEV) ACROSS MULTIPLE LINES IN THE TREATMENT IN GLIOBLASTOMA (GBM)